IDRA logo

Idera Pharmaceuticals (IDRA) Current Liabilities

Annual Current Liabilities

$4.86 M
-$2.17 M-30.81%

December 31, 2021

Summary

Performance

1-Year Change

-30.81%

3-Year Change

-46.09%

5-Year Change

-51.9%

15-Year Change

-51.9%

IDRA Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$54.52 M
IDRA annual total current liabilities is currently -91.08% below its historical high of $54.52 million

3-Year Low

$4.86 M
IDRA annual total current liabilities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
IDRA previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
IDRA next annual earnings announcement has not yet been scheduled

OtherIDRAbalance sheetmetrics:

Annual Total Liabilities

$5.41 M
IDRA annual total liabilities is $5.41 million

Annual Total Long Term Liabilities

$549.00 K
IDRA annual total long term liabilities is $549.00 thousand

Annual Total Assets

$34.86 M
IDRA annual total assets is $34.86 million

Annual Current Assets

$34.04 M
IDRA annual total current assets is $34.04 million

Quarterly Current Liabilities

$19.23 M
+$14.49 M+306.06%

September 30, 2022

Summary

Performance

3-Month Change

+306.06%

1-Year Change

+245.51%

3-Year Change

+147.63%

5-Year Change

+146.05%

IDRA Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$54.52 M
IDRA quarterly total current liabilities is currently -64.72% below its historical high of $54.52 million

3-Year Low

$3.80 M
IDRA quarterly total current liabilities is currently +406.61% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
IDRA previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
IDRA next earnings announcement has not yet been scheduled

OtherIDRAbalance sheetmetrics:

Quarterly Total Liabilities

$82.91 M
IDRA quarterly total liabilities is $82.91 million

Quarterly Long Term Liabilities

$63.68 M
IDRA quarterly total long term liabilities is $63.68 million

Quarterly Total Assets

$103.68 M
IDRA quarterly total assets is $103.68 million

Quarterly Current Assets

$30.07 M
IDRA quarterly total current assets is $30.07 million

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

Annual Current Liabilities

$4.86 M
IDRA annual total current liabilities is $4.86 million

Annual Accounts Payable

$565.00 K
IDRA annual accounts payable is $565.00 thousand

Annual Short Term Debt

$209.00 K
IDRA annual short term debt is $209.00 thousand

IDRA Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-30.8%+245.5%
3 y3 years-46.1%+147.6%
5 y5 years-51.9%+146.1%

IDRA Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat lowat high-80.3%
5 y5-year-91.1%at low-64.7%-80.3%
alltimeall time-91.1%-61.8%-64.7%-92.4%

Idera Pharmaceuticals Current Liabilities History

DateAnnualQuarterly
Sep 2022
-
$19.23 M(+306.1%)
Jun 2022
-
$4.74 M(+24.8%)
Mar 2022
-
$3.80 M(-21.9%)
Dec 2021
$4.86 M(-30.8%)
$4.86 M(-12.6%)
Sep 2021
-
$5.57 M(-7.7%)
Jun 2021
-
$6.03 M(+20.7%)
Mar 2021
-
$5.00 M(-28.9%)
Dec 2020
$7.03 M(-87.1%)
$7.03 M(+3.3%)
Sep 2020
-
$6.80 M(-9.7%)
Jun 2020
-
$7.53 M(-78.0%)
Mar 2020
-
$34.21 M(-37.2%)
Dec 2019
$54.52 M(+504.5%)
$54.52 M(+602.0%)
Sep 2019
-
$7.77 M(+17.9%)
Jun 2019
-
$6.58 M(+4.9%)
Mar 2019
-
$6.28 M(-30.4%)
Dec 2018
$9.02 M(-10.8%)
$9.02 M(-12.5%)
Sep 2018
-
$10.30 M(-26.8%)
Jun 2018
-
$14.07 M(+13.5%)
Mar 2018
-
$12.40 M(+22.7%)
Dec 2017
$10.11 M(+8.1%)
$10.11 M(+29.3%)
Sep 2017
-
$7.82 M(+6.3%)
Jun 2017
-
$7.35 M(+4.9%)
Mar 2017
-
$7.01 M(-25.1%)
Dec 2016
$9.35 M(+37.2%)
$9.35 M(+19.0%)
Sep 2016
-
$7.86 M(+11.2%)
Jun 2016
-
$7.06 M(+37.5%)
Mar 2016
-
$5.13 M(-24.7%)
Dec 2015
$6.82 M(-3.3%)
$6.82 M(+19.4%)
Sep 2015
-
$5.71 M(-12.3%)
Jun 2015
-
$6.50 M(+5.9%)
Mar 2015
-
$6.14 M(-12.9%)
Dec 2014
$7.05 M(+59.8%)
$7.05 M(+4.6%)
Sep 2014
-
$6.74 M(+7.9%)
Jun 2014
-
$6.25 M(+16.7%)
Mar 2014
-
$5.35 M(+21.4%)
Dec 2013
$4.41 M(+6.8%)
$4.41 M(+79.4%)
Sep 2013
-
$2.46 M(-18.7%)
Jun 2013
-
$3.02 M(-25.8%)
Mar 2013
-
$4.07 M(-1.4%)
Dec 2012
$4.13 M(-32.1%)
$4.13 M(-2.7%)
Sep 2012
-
$4.25 M(-11.7%)
Jun 2012
-
$4.81 M(-12.3%)
Mar 2012
-
$5.49 M(-9.8%)
Dec 2011
$6.08 M(+71.9%)
$6.08 M(+69.4%)
Sep 2011
-
$3.59 M(-1.9%)
Jun 2011
-
$3.66 M(+5.4%)
Mar 2011
-
$3.47 M(-1.9%)
DateAnnualQuarterly
Dec 2010
$3.54 M(-75.1%)
$3.54 M(-52.6%)
Sep 2010
-
$7.46 M(-7.5%)
Jun 2010
-
$8.07 M(-14.2%)
Mar 2010
-
$9.40 M(-33.9%)
Dec 2009
$14.21 M(-42.8%)
$14.21 M(-29.7%)
Sep 2009
-
$20.21 M(-20.3%)
Jun 2009
-
$25.37 M(+2.1%)
Mar 2009
-
$24.84 M(-0.1%)
Dec 2008
$24.86 M(+172.6%)
$24.86 M(-2.4%)
Sep 2008
-
$25.46 M(+0.4%)
Jun 2008
-
$25.37 M(-3.6%)
Mar 2008
-
$26.32 M(+188.6%)
Dec 2007
$9.12 M(+13.7%)
$9.12 M(+0.1%)
Sep 2007
-
$9.11 M(-6.2%)
Jun 2007
-
$9.71 M(+13.4%)
Mar 2007
-
$8.57 M(+6.9%)
Dec 2006
$8.02 M(+97.9%)
$8.02 M(+113.8%)
Sep 2006
-
$3.75 M(-17.6%)
Jun 2006
-
$4.55 M(-0.4%)
Mar 2006
-
$4.57 M(+12.7%)
Dec 2005
$4.05 M(+118.1%)
$4.05 M(+5.1%)
Sep 2005
-
$3.86 M(+6.7%)
Jun 2005
-
$3.62 M(+108.5%)
Mar 2005
-
$1.73 M(-6.7%)
Dec 2004
$1.86 M(-42.5%)
$1.86 M(-18.2%)
Sep 2004
-
$2.27 M(+30.5%)
Jun 2004
-
$1.74 M(-47.5%)
Mar 2004
-
$3.32 M(+2.6%)
Dec 2003
$3.23 M(+51.4%)
$3.23 M(+5.3%)
Sep 2003
-
$3.07 M(+4.4%)
Jun 2003
-
$2.94 M(+101.6%)
Mar 2003
-
$1.46 M(-31.7%)
Dec 2002
$2.14 M(-56.5%)
$2.14 M(-28.4%)
Sep 2002
-
$2.98 M(-37.5%)
Jun 2002
-
$4.77 M(-10.4%)
Mar 2002
-
$5.33 M(+8.6%)
Dec 2001
$4.91 M(-40.0%)
$4.91 M(+5.1%)
Sep 2001
-
$4.67 M(-25.9%)
Jun 2001
-
$6.30 M(-26.0%)
Mar 2001
-
$8.51 M(+4.1%)
Dec 2000
$8.18 M(-11.1%)
$8.18 M(-4.2%)
Sep 2000
-
$8.53 M(-48.3%)
Jun 2000
-
$16.51 M(-4.7%)
Mar 2000
-
$17.31 M
Dec 1999
$9.20 M(-26.4%)
-
Dec 1998
$12.51 M(-55.1%)
-
Dec 1997
$27.84 M(+188.5%)
-
Dec 1996
$9.65 M
-

FAQ

  • What is Idera Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for Idera Pharmaceuticals?
  • What is Idera Pharmaceuticals annual current liabilities year-on-year change?
  • What is Idera Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Idera Pharmaceuticals?
  • What is Idera Pharmaceuticals quarterly current liabilities year-on-year change?

What is Idera Pharmaceuticals annual total current liabilities?

The current annual current liabilities of IDRA is $4.86 M

What is the all time high annual current liabilities for Idera Pharmaceuticals?

Idera Pharmaceuticals all-time high annual total current liabilities is $54.52 M

What is Idera Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, IDRA annual total current liabilities has changed by -$2.17 M (-30.81%)

What is Idera Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of IDRA is $19.23 M

What is the all time high quarterly current liabilities for Idera Pharmaceuticals?

Idera Pharmaceuticals all-time high quarterly total current liabilities is $54.52 M

What is Idera Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, IDRA quarterly total current liabilities has changed by +$13.66 M (+245.51%)